The function of the mechanosensitive, multimeric blood protein von Willebrand factor (VWF) is dependent on its size. We tested the hypothesis that VWF may self-associate on the platelet glycoprotein Ib␣ (GpIb␣) receptor under hydrodynamic shear. Consistent with this proposition, whereas Alexa-488-conjugated VWF (VWF-488) bound platelets at modest levels, addition of unlabeled VWF enhanced the extent of VWF-488 binding. Recombinant VWF lacking the A1-domain was conjugated with Alexa-488 to produce ⌬A1-488. Although ⌬A1-488 alone did not bind platelets under shear, this protein bound GpIb␣ on addition of either purified plasma VWF or recombinant full-length VWF. The extent of self-association increased with applied shear stress more than ϳ 60 to 70 dyne/cm 2 . ⌬A1-488 bound platelets in the milieu of plasma. On application of fluid shear to whole blood, half of the activated platelets had ⌬A1-488 bound, suggesting that VWF self-association may be necessary for cell activation. Shearing platelets with 6-m beads bearing either immobilized VWF or anti-GpIb␣ mAb resulted in cell activation at shear stress down to 2 to 5 dyne/cm 2 . Taken together, the data suggest that fluid shear in circulation can increase the effective size of VWF bound to platelet GpIb␣ via protein self-association. This can trigger mechanotransduction and cell activation by enhancing the drag force applied on the cell-surface receptor. (Blood. 2010;116(19):3990-3998)
Introduction
von Willebrand factor (VWF) is a large, multidomain glycoprotein found in normal blood at concentrations of approximately 10 g/mL. 1 The protein plays an important role in hemostasis by both carrying the coagulation protein factor VIII (FVIII) in circulation and by regulating the adhesion of platelets to sites of vascular injury. Whereas the DЈD3 domain of VWF binds FVIII, the A1 and C1 domains engage platelet receptors glycoprotein Ib␣ (GPIb␣) and ␣ IIb ␤ 3 (GPIIb-IIIa), respectively. Monomeric VWF has a molecular mass of approximately 250 kDa. This unit further polymerizes, via disulfide linkage formation in the endoplasmic reticulum and Golgi of endothelial cells and megakaryocytes. Multimeric VWF size ranges from 0.5 to 20 MDa. 2 Ultra/unusuallylarge VWF is secreted from the Weibel-Palade bodies of endothelial cells on stimulation with a variety of agonists associated with inflammation and thrombosis, including thrombin, histamine, and tumor necrosis factor-␣.
The hemostatic potential of VWF increases with protein size and the magnitude of the applied hydrodynamic shear. 3, 4 Ultra/ unusually-large VWF secreted from endothelial cells under shear is extended in the form of strings or bundles on the vessel wall. 5, 6 Shear-mediated extension enhances cleavage of the cryptic Y 1605 -M 1606 bond within the VWF-A2 domain by the constitutively active blood metalloprotease, ADAMTS13. In addition to cleavage when immobilized on the endothelium, VWF subjected to fluid shear in flowing blood 7 and on platelets 8 is also susceptible to proteolysis by ADAMTS13. Together, these mechanisms reduce and regulate the VWF multimer distribution in circulation. In support of a role for ADAMTS13 in regulating VWF activity in blood, ADAMTS13 Ϫ/Ϫ mice exhibit prothrombotic phenotype. 9, 10 ADAMTS13 deficiency in humans is also associated with thrombotic thrombocytopenic purpura, a condition characterized by the existence of ultra/ unusually-large VWF in circulation, thrombocytopenia, and thrombosis in the microvasculature. 3, 11 Although a number of studies have focused on the role of ADAMTS13 in regulating VWF size under hydrodynamic shear, fewer investigations examine the contributions of VWF selfassociation to this process. The self-association of VWF was first reported by Savage et al 12 who demonstrated that the homotypic interaction between VWF in solution and VWF immobilized on substrates contributes to platelet adhesion in a parallel plate flow chamber-based model of vascular injury. Studies performed in a cone-plate viscometer where purified VWF was subjected to shear and then analyzed using light scattering demonstrated that VWF self-association in solution proceeds in a fluid shear-dependent manner and can be detected at shear rates more than 2000/s. 13 Later studies demonstrate the formation of bundles or networks of VWF both on collagen 14 and on ␣ v ␤ 3 integrin on the endothelial cell surface. 6 Such interactions may also involve the self-association of VWF. These data suggest that the self-association of VWF may be an additional mechanism regulating protein size in circulation.
In the current manuscript, we tested the hypothesis that VWF self-association can take place on the surface of the platelet receptor GpIb␣. Using experimental conditions where the applied shear rate and media viscosity were varied independently, we demonstrate that the extent of VWF self-association depends on the magnitude of applied shear stress. It proceeds optimally above 60 to 70 dyne/cm 2 in both reconstituted systems and whole blood, conditions observed in some arterioles, stenotic vessels, and prosthetic cardiovascular devices. 15, 16 Thus, in addition to regulating VWF-GpIb␣ binding affinity, fluid shear driven VWF selfassociation may also alter the avidity of this molecular interaction. Using a model of shear-induced platelet activation (SIPAct), 13 we show that the self-associated VWF formed on the mechanosensitive receptor GpIb␣ is functional. This self-associated protein complex effectively increases the apparent size of the globular domain of GpIb␣, and it facilitates platelet activation under shear.
Methods

Reagents
Unless stated otherwise, all monoclonal antibodies (mAbs) were IgGs from mouse origin directed against human antigens. Anti-VWF Abs include rabbit polyclonal Ab (Dako North America), nonfunction blocking mAb AVW-1 against the C-terminus (GTI Diagnostics), mAb AVW-3 against VWF-A1 domain (GTI Diagnostics), mAb SZ-123 17 against VWF-A3 domain (gift from Dr C. Ruan, Suzhou University, Suzhou, China) and 242.6 18 against VWF propeptide (gift from Dr R. Montgomery, BloodCenter of Wisconsin, Milwaukee, WI). Anti-GpIb␣/CD42b function blocking mAbs are AP-1 (GTI Diagnostics), AK2 (Millipore), and HIP1 (BD Biosciences). Anti-GpIb␣ VM16d (Cell Sciences) does not block GpIb␣ binding to VWF. Anti-FVIII mAb ESH-4 blocks VWF binding to FVIII (American Diagnostica). Function blocking anti-GpIIb-IIIa (CD41b/ CD61; ␣ IIb ␤ 3 ) mAbs include HIP8 (eBioscience), 7E3 (ATCC), and humanized mAb c7E3 Fab (ReoPro, Eli Lilly). Fluorescent-conjugated mAbs used to label platelets are CD61-peridinin chlorophyll protein (PerCP; BD Biosciences) and anti-CD31 (platelet endothelial cell adhesion molecule-1) mAb WM59 that was either conjugated with phycoerythrin (PE; BD Biosciences) or PerCP-eFluor-710 (eBioscience). Annexin V conjugated with PE (BD Biosciences) and PE/Cy5 (BioVision) were used in this study.
Human plasma and recombinant VWF
Multimeric human plasma VWF (pVWF) was purified from plasma cryoprecipitate obtained from the Community Blood Bank. 19 Several molecular biology steps described in supplemental Methods (available on the Blood Web site; see the Supplemental Materials link at the top of the online article) were undertaken to express full-length VWF (rVWF) and VWF lacking the A1-domain (⌬A1-VWF) in Chinese Hamster Ovary (CHO) cells. To this end, a CHO cell line overexpressing furin called "CHO-furin" was established. The 8.5-kb VWF cDNA available in pCDNA 3.1 (neomycin) from our earlier study 19 was transferred into pCDNA 3.1 Hygro(ϩ) (Invitrogen) to generate the vector pCDNA⌬3-VWF. In addition, the A1 domain of VWF was deleted in pCDNA⌬3-VWF, and this resulted in pCDNA⌬3-⌬A1VWF. rVWF and ⌬A1-VWF were expressed in CHO-furin cells by transient transfection of pCDNA⌬3-VWF and pCDNA⌬3-VWF⌬A1 using Fugene 6 (Roche Diagnostics). Twelve to 18 hours after transfection, media was changed to PROCHO-AT serum-free media (Lonza Walkersville). A total of 200 mL of culture supernatant collected after 48 hours was centrifuged to remove cells and cell debris, and VWF was purified using Fractogel EMD-TMAE (EMD Biosciences) ion-exchange chromatography (supplemental Methods). This procedure yielded 5 to 6 mL of each protein at approximately 12 g/mL.
When necessary, primary amine residues in pVWF, rVWF, and ⌬A1-VWF were fluorescently labeled using either an Alexa-488 conjugation kit or fluorescein isothiocyanate (FITC; Invitrogen) as described earlier. 20 VWF multimer distribution was similar before and after labeling.
Characterizing VWF
Agarose-Western blot analysis and silver staining of sodium dodecyl sulfate-polyacrylamide gel electrophoresis gels were performed as described previously 21 to determine VWF multimer distribution and to assay for protein purity. Protein/VWF concentration was measured using both the Coomassie/Bradford protein assay kit (Thermo-Pierce), and the cytometrybead assay described earlier. 19 Function assays described in supplemental Methods were performed to characterize the recombinant proteins. Here, enzyme-linked immunosorbent assay measured: (1) the efficiency with which VWFpp (VWF propeptide) was removed from recombinant VWF when expressed in CHO-furin cells, (2) the efficiency of VWF-DЈD3 domain binding to FVIII, (3) the binding of VWF to human collagen type III, and (4) the absence of A1 domain in purified ⌬A1-VWF. Other assays confirmed that beads coupled to ⌬A1-VWF do not bind platelets under shear. Finally, experiments were performed to confirm cleavage of VWF by recombinant ADAMTS13. For the last study, recombinant ADAMTS13 was produced using the vector pCAGG-hADAMTS13, 22 a kind gift from Dr Kenji Soejima (Chemo-Sero-Therapeutic Research Institute, Kaketsuken, Japan).
Beads bearing antibodies
Carbodiimide chemistry was applied to covalently couple a variety of antibodies directed against human antigens onto 6-m carboxylate polystyrene beads (Polysciences) 23 (supplemental Methods). The immobilized reagents include polyclonal anti-VWF Ab (Dako North America) and mAbs AVW-1 and AP-1. "VWF-beads" were made by incubating 25 g/mL pVWF with 3 ϫ 10 7 AVW-1 bearing beads/mL for 20 minutes at room temperature, followed by blocking with 2% bovine serum albumin for more than 2 hours. Beads with polyclonal Ab were used to quantify VWF concentrations in complex mixtures using the cytometry-bead assay. 19 The "anti-GpIb␣-beads" with immobilized mAb AP-1 were applied in the SIPAct assay described next.
SIPAct
Functional studies were performed with blood drawn in sodium citrate from healthy nonsmoking human volunteers. The protocol used was approved by the University at Buffalo Institutional Review Board. All studies were completed within 2 to 2.5 hours of blood draw.
Platelet-rich plasma (PRP) was obtained by centrifugation of blood at 150g for 12 minutes. 13 In typical runs, PRP was diluted to 7.5 to 10 ϫ 10 6 platelets/mL in HEPES buffer (30mM N-2-hydroxyethylpiperazine-NЈ-2-ethanesulfonic acid, 110mM NaCl, 10mM KCl, 1mM MgCl 2 , 0.1% human serum albumin, pH 7.3) containing 1.5mM CaCl 2 along with 5 g/mL Alexa-488/FITC-conjugated pVWF (or rVWF) and 5 to 15 g/mL unconjugated pVWF. A VT550 cone-plate viscometer (Thermo-Haake) with a 0.5°cone was used to mix this solution at shear rates up to 9600/s. A total of 5 L of sample withdrawn at indicated time points were either diluted in 100 to 200 L of HEPES buffer and read immediately (within 1 minute) using a FACSCalibur flow cytometer (BD Biosciences), or these were incubated with 1 L of PE/PE-Cy5-labeled annexin V and 5 L of HEPES buffer containing 10mM CaCl 2 for additional 5 minutes at 37°C. After incubation, samples containing annexin V-labeled platelets were diluted using 200 L of HEPES buffer with 5mM CaCl 2 , and analyzed using a flow cytometer. Control experiments confirmed that, once bound, pVWF conjugated with Alexa-488 or FITC (pVWF-488/FITC) did not dissociate from platelets in 5 minutes. Platelets were labeled with CD61-PerCP or fluorescent anti-CD31 mAbs either before shear application or during the 5-minute incubation step. All analyses were performed on a population of singlet platelets. VWF-488/FITC binding and platelet activation quantify the percentage of platelets binding greater than baseline (time ϭ 0) levels of VWF-488/FITC and annexin V, respectively.
Many variations to the aforementioned protocol were applied. In blocking studies, platelets were incubated with 25 g/mL anti-GpIb␣ or GpIIb-IIIa mAbs for more than 10 minutes at room temperature before shear application. In some runs, 1.5% (wt/vol) dextran (molecular mass 2 ϫ 10 6 ) was added to the mixture to double media viscosity. In other runs, VWF-deficient plasma (Aniara Diagnostics) replaced HEPES buffer. VWF concentration in this deficient plasma was less than 1% normal levels. In whole blood studies, 100 L of blood was mixed with 4 to 5 g/mL ⌬A1-488 at various shear rates in the viscometer. Typically, blood was diluted to 66% of its original concentration in this assay. In studies where VWF-or anti-GpIb␣-bearing polystyrene beads were shear mixed with
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Confocal microscopy
A total of 150 L of PRP was sheared with 4 g/mL ⌬A1-488 at 9600/s for 2 minutes. The sheared sample was fixed in 0.5% paraformaldehyde overnight at 4°C. Cells were then pelleted at 800g for 10 minutes and washed thrice in HEPES modified Tyrode buffer (12mM NaHCO 3 , 138mM NaCl, 5.5mM glucose, 2.9mM KCl, 10mM N-2-hydroxyethylpiperazine-NЈ-2-ethanesulfonic acid, pH 7.4). Then, 10 g/mL anti-GpIb␣ mAb VM16d was added for 20 minutes at 4°C. Cells were again washed with HEPES-modified Tyrode buffer before incubation with 1:1000 diluted Alexa-647 conjugated antimouse Ab (Invitrogen) for 20 minutes. Samples were then washed once more and prepared for microscopy examination. ProLong Gold antifade reagent (Invitrogen) was used to cure the samples during the mounting step. Images were acquired using a Zeiss LSM 510 Meta NLO confocal microscope with plan-apochromat 63ϫ/1.4 oil objective.
Statistics
Data are mean plus or minus SEM for more than or equal to 3 independent experiments. Analysis of variance was applied for comparison between multiple treatments. P less than .05 was considered significant.
Results
Exogenous unlabeled pVWF augments pVWF-488 binding to platelets under fluid shear
Flow cytometry was applied to measure the binding of purified pVWF to human blood platelets at a shear rate of 9600/s in a cone-plate viscometer ( Figure 1 ). Studies were performed using Alexa-488-conjugated pVWF (pVWF-488) either in the presence or absence of additional exogenous unlabeled pVWF. In control runs, 5g/mL pVWF-488 activated platelets to a similar extent as 5 g/mL unlabeled pVWF (supplemental Figure 1) . Thus, Alexa-488 labeling of pVWF does not alter protein function. Annexin V was applied as a marker of SIPAct because this is superior to other measures, including microparticle formation, 13 platelet P-selectin expression 13 (supplemental Figure 2) , and GpIIb-IIIa conformationsensitive mAb PAC-1 (supplemental Figure 2) . Platelet activation is quantified as the percentage of cells binding greater than a threshold level of annexin V because only cells with high cytosolic calcium expose phosphatidylserine on their surface. 24 These activated cells bind annexin V at 2 to 3 orders of magnitude greater levels compared with unactivated cells ( Figure 1A) . In contrast to annexin V, similar to previous reports, 25 shear-induced pVWF-488 binding only causes a modest increase in fluorescence signal ( Figure 1A ). In this case also, we quantify pVWF-488 binding to platelets based on the cell fraction that binds greater than baseline (time ϭ 0) levels of pVWF-488. Presentation of the results based on the measured mean fluorescence intensity yields similar conclusions (supplemental Figure 3) .
When 5 g/mL pVWF-488 was applied alone under shear, approximately 15% of the single platelets bound the protein at 4 minutes ( Figure 1B ) and 7% of these cells were activated ( Figure 1C) . Although the addition of unlabeled 15 g/mL pVWF may be expected to compete away the binding of pVWF-488, we instead observed a significant increase in the binding of the fluorescent molecule. Accompanying this increased pVWF-488 binding was an approximately 30% increase in annexin-PE binding to cells. A fraction of platelets with bound pVWF-488 remained inactive (top left quadrant), suggesting that VWF binding alone is insufficient to trigger platelet activation. Similar augmentation of pVWF-488 binding and platelet activation was observed on addition of unlabeled pVWF over a range ( Figure 1D-E) . Thus, our A total of 7.5 ϫ 10 6 human platelets/mL was sheared with Alexa-488-conjugated plasma VWF (pVWF-488) in the absence or presence of unlabeled pVWF in a cone-plate viscometer at 9600/s. While pVWF-488 and pVWF were fixed at 5 g/mL and 15 g/mL, respectively, in panels A to C, this was varied over a wider range in panels D and E. In all cases, samples withdrawn at indicated times were incubated with CD31 PerCP-eFluor 710 and annexin-PE for an additional 5 minutes before cytometry analysis. (D-E) Identical to panels B and C, respectively, except for the use of a wider concentration range of pVWF-488/pVWF. As seen, pVWF-488 binding and platelet activation are augmented on addition of unlabeled pVWF. This is blocked by 25 g/mL anti-GpIb␣ but not anti-GpIIb-IIIa mAb. *P Ͻ .05 with respect to all other treatments except blocking with GpIIb-IIIa mAb alone.
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For at STATE UNIV OF N Y AT BUFFAL on December 4, 2011. bloodjournal.hematologylibrary.org From observations are not limited to a narrow range of pVWF-488/ pVWF concentrations. Binding of both pVWF-488 and annexin to platelets was blocked by anti-GpIb␣ mAb (clone AK2) but not blocking mAb against GpIIb-IIIa (HIP8). In control studies, neither the addition of unlabeled bovine serum albumin in place of unlabeled pVWF nor the addition of bovine serum albumin-488 in place of pVWF-488 resulted in such an increase in fluorescence signal (supplemental Figure 4) .
⌬A1-488 binds platelets only in the presence of full-length VWF and fluid shear
Augmented pVWF-488 binding on addition of unlabeled pVWF in Figure 1 may be the result of the self-association of VWF on platelet receptor GpIb␣. 12, 13 To test this possibility, we expressed multimeric rVWF and VWF that lacked the A1 domain (⌬A1-VWF; Figure 2 ). To this end, a CHO cell line overexpressing furin was first created (Figure 2A ). These cells are green because of the presence of the green fluorescent protein variant (hrGFP-II) that is driven by the internal ribosome entry site. Recombinant VWF expressed in these CHO-furin cells lacked the propeptide sequence (supplemental Figure 5A) . Although full-length rVWF expressed all 2050 amino acids of the mature protein, ⌬A1-VWF lacked amino acids from 1242 to 1479. Both proteins were expressed and purified from CHO cells as multimers with up to 5 to 8 protomer units ( Figure 2B ). As expected, ⌬A1-VWF did not recognize a mAb directed against the VWF A1-domain (supplemental Figure  5B) , and it also did not bind platelets via GpIb␣ (supplemental Figure 5C ). Both proteins appear to be folded well because cleavage by metalloprotease ADAMTS13 required the addition of 1.5M urea to expose the buried Tyr 1605 -Met 1606 cleavage site (supplemental Figure 5D ). These proteins also bound FVIII via the DЈD3 domain efficiently (supplemental Figure 5E) . Finally, consistent with the literature, 26-28 ⌬A1-VWF displayed binding for type III collagen (supplemental Figure 5F ). Thus, ⌬A1-VWF displayed similar properties as rVWF except that it lacked A1-domain function.
We monitored the binding of ⌬A1-VWF conjugated with Alexa-488 (termed ⌬A1-488) to platelets in the presence of either pVWF ( Figure 2C ) or rVWF ( Figure 2D ). In both cases, whereas the binding of ⌬A1-488 to platelets was low, this was augmented in the presence of unlabeled full-length p/rVWF. The low ⌬A1-488 binding observed in the absence of full-length VWF is probably the result of residual VWF present in the diluted PRP used in this assay. ⌬A1-488 binding in the presence of full-length p/rVWF was dependent on VWF-GpIb␣ interaction, and it was independent of platelet GpIIb-IIIa. These data are consistent with the proposition that VWF self-associates on platelet GpIb␣ on shear.
The self-association of VWF on platelets is a physical phenomenon that can proceed in the absence of platelet activation or other plasma components. In this regard, ⌬A1-488 binding to formalinfixed platelets was enhanced on addition of pVWF. This binding proceeded efficiently at shear rate of more than 5800/s, and it was abrogated by anti-GpIb␣ mAb (supplemental Figure 6) .
In additional runs, unlabeled ⌬A1-VWF was added in the presence of pVWF to determine its effect on platelet activation. Here, we observed a decrease in VWF binding to platelets ( Figure  2E ) and platelet activation ( Figure 2F ) on addition of ⌬A1-VWF. Regardless of the reduced binding, significant platelet activation was noted in the presence of ⌬A1-VWF. Overall, the studies demonstrate the utility of ⌬A1-488 for the detection of protein self-association. Association between ⌬A1-VWF and pVWF in suspension under shear may reduce/mask the A1-domain of pVWF. This may account for the reduced cell activation in studies with unlabeled ⌬A1-VWF.
VWF self-association occurs in whole blood
The binding of ⌬A1-488 to platelets was measured both in the presence of blood plasma and in whole blood (Figure 3) . In some runs ( Figure 3A) , FITC-conjugated pVWF (pVWF-FITC) was sheared with platelets in the presence of VWF-deficient plasma. Platelets were labeled with CD31-PE, and annexin-PE-Cy5 was used to monitor cell activation. Here, consistent with the proposition that VWF self-association can take place in plasma, we observed augmented VWF-FITC binding to platelet GpIb␣ on addition of unlabeled pVWF. In other experiments, shearing PRP with ⌬A1-488 also resulted in the binding of the fluorescent VWF-mutant to platelets ( Figure 3B ). Here, confocal microscopy images show that ⌬A1-488 localized on only a small fraction of platelet GpIb␣ receptors, and this protein appeared in the form of clusters that would be expected if it is self-associated. Fluid shear is required for this self-association process because VWF clusters (C-D) ⌬A1-VWF was labeled with Alexa-488 to produce ⌬A1-488. ⌬A1-488 bound platelets in the presence of both 5 g/mL plasma (C, pVWF) and recombinant full-length VWF (D, rVWF). Shear rate is 9600/s. ⌬A1-488 binding to platelets is the result of VWF self-association. Binding was blocked by mAbs against GpIb␣ but not GpIIb-IIIa. (E-F) A total of 5 g/mL pVWF was shear mixed with 5 g/mL ⌬A1-VWF at 9600/s in the presence or absence of anti-GpIb␣/GpIIb-IIIa mAbs for the indicated time. Two samples were withdrawn. The total VWF bound to platelets was measured in one sample using FITC-conjugated rabbit anti-human VWF polyclonal Ab (E). Platelet activation was quantified in the other using annexin-FITC. Both pVWF binding and cell activation were partially reduced by ⌬A1-VWF in a GpIb␣-dependent manner. Shear protocol in all panels is identical to Figure 1 . *P Ͻ .05 with respect to all other treatments except blocking with GpIIb-IIIa mAbs. †P Ͻ .05 with respect to all other treatments.
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containing ⌬A1-488 do not appear on the surface of platelets held under static conditions (supplemental Figure 7) . ⌬A1-488 also bound platelets in the milieu of whole blood ( Figure 3C-D) . Fluid shear both augmented the binding of ⌬A1-488 to platelets and cell activation. Approximately 50% of platelets that were activated were bound to ⌬A1-488, and this suggests an important role of VWF self-association in triggering SIPAct. Control cytometry dot plots for the whole blood studies are provided in supplemental Figure 8 .
VWF self-association depends on the applied shear stress but not the shear rate VWF binding to platelets 25 and platelet activation 13 are augmented by the applied shear stress. We tested whether VWF selfassociation is also shear-stress dependent by monitoring the enhanced binding of pVWF-FITC to platelets on addition of unlabeled pVWF (Figure 4 ). Whereas shear rate (G) was varied in some runs, media viscosity () was increased in others by addition of dextran; 1.5% dextran doubles medium viscosity. Thus, the magnitude of applied shear stress () at a given shear rate ( ϭ ϫ G) is doubled for the Newtonian fluid used in this study. Here, VWF-FITC binding and platelet activation showed very similar dependence on both the applied shear rate and shear stress. VWF self-association, quantified as the extent of pVWF-FITC binding in the presence of unlabeled pVWF compared with that in the absence of pVWF, was augmented significantly above all other treatments on addition of dextran at shear rate more than 7200/s. The data suggest that VWF-self-association, like SIPAct, is a shear-stress-dependent phenomenon.
Drag force applied on platelet GpIb␣ triggers mechanotransduction
We hypothesize that the hydrodynamic force applied on platelet GpIb␣ after VWF self-association on the receptor may trigger mechanotransduction. This outside-in signaling then contributes to SIPAct. To test this possibility, beads bearing both immobilized VWF (pVWF-beads) and anti-GpIb␣ mAb AP-1 (anti-GpIb␣-beads) were created ( Figure 5 ). These beads were mixed with platelets at various shear rates.
Because the drag force applied by VWF immobilized on beads is substantially higher than free VWF in solution, 29 we expected to observe enhanced platelet activation at lower shear rates in studies Figure 3 . VWF self-association in the presence of plasma proteins and in whole blood. (A) A total of 30 ϫ 10 6 platelets/mL was diluted in 100% VWF-deficient plasma, instead of HEPES buffer, along with 10 g/ mL FITC-conjugated pVWF (pVWF-FITC). The sample was sheared at 9600/s for 4 minutes, either in the presence or absence of 10 g/mL unconjugated pVWF and anti-GpIb␣ blocking mAb HIP1. A total of 60 g/mL 7E3 was present during all runs to prevent VWF interaction with GpIIb-IIIa. Samples withdrawn were incubated for 5 minutes with CD31-PE and annexin-PE/Cy5 before cytometry analysis. *P Ͻ .05 with respect to all other treatments. (B) A total of 5 g/mL ⌬A1-488 (green) was added to PRP and sheared at 9600/s for 2 minutes. Samples fixed in 0.5% paraformaldehyde were labeled with VM16d (anti-GpIb␣ mAb, red) and examined using confocal microscopy. (C) A total of 5 g/mL ⌬A1-488 was added to whole blood and subjected to shear at 4700/s. Samples withdrawn at 4 minutes was incubated with CD31 PerCP-eFluor 710 to identify platelets and annexin-PE to monitor cell activation. Cytometry dot plot shows ⌬A1-488 bound to inactive (top left quadrant) and activated platelets (top right). (D) Distribution of active platelets either with or without ⌬A1-488 bound. Percentage is based on total number of platelets read in the cytometer. *Platelet activation (top right plus bottom right) is higher at 4 minutes compared with 0 minutes at this shear rate (P Ͻ .05). †Platelet activation at 4 minutes at this shear rate is higher compared with 300/s (P Ͻ .05). Figure 5A-B,D) . Consistent with this proposition, after 3 minutes of shear at 1863/s, 17% of the platelets were activated in the presence of pVWF-beads. Negligible platelet activation occurs at these shear rates in the absence of beads (Figure 4 ). Approximately two-thirds of the activated platelets were in solution, free of the pVWF-beads. This is probably the result of the labile nature of the VWF-GpIb␣ bond. The extent of platelet activation increased with the magnitude of applied shear rate, with significant levels of platelet activation being observed at shear rates down to 932/s (shear stress of ϳ9 dyne/cm 2 ). In control runs, both VWF-bead binding to platelets and cell activation were blocked by anti-VWF A1 domain mAb AVW-3 and anti-GpIb␣ mAb AK2.
In studies performed with anti-GpIb␣-beads also, we observed enhanced platelet activation that was shear mediated. These beads triggered platelet activation at shear rates down to 233/s ( Figure  5C ,E). In this case, a majority of the activated platelets were associated with the beads unlike the previous case where they were in solution. This may be the result of the high affinity antigenantibody interaction that creates a stronger molecular bond. Platelet binding to beads and cell activation were abrogated by soluble anti-GpIb␣ mAb AP-1.
Discussion
This study demonstrates that robust, shear-dependent, VWF selfassociation takes place on the platelet GpIb␣ receptor. VWF self-association occurs in the milieu of plasma and also in whole blood. Both the magnitude of VWF self-association and platelet activation vary as a function of the applied shear stress, but not shear rate. They proceed optimally above 60 dyne/cm 2 . The strong correlation between the shear requirements for VWF selfassociation and SIPAct 13 suggests that VWF self-association is a necessary process that accompanies platelet activation. These overall conclusions were consistently observed regardless of the FITC/Alexa-488 labeling protocol used to detect VWF-binding or the annexin-fluorophore used to measure platelet activation. Taken together with prior publications, the results suggest 3 independent roles for fluid shear in augmenting: (1) the affinity of VWF-GpIb␣ binding, (2) VWF self-association on GpIb␣, and (3) platelet mechanotransduction via GpIb␣.
Shear dependent changes in VWF conformation enhances VWF-GpIb␣ binding
The application of fluid shear results in conformation changes in VWF. Such conformation changes in solution result in large-scale elongation/uncoiling of VWF 30 and the exposure of protein hydrophobic domains 21, 31 at shear rates more than 5000/s (shear stress ϳ 50 dyne/cm 2 ). Small-angle scattering studies show that smaller-length scale changes may occur at lower shear rates. 21 Shear driven protein conformation change also enhances the binding of VWF to platelet GpIb␣, 25 and it exposes a cryptic proteolytic site that is hidden within the native A2-domain. 32 Point mutations in VWF or GpIb␣ associated with von Willebrand disease, either von Willebrand disease type 2B or platelet-type von Willebrand disease, enhance VWF binding affinity and platelet activation at low shear rates. 33 In this context, because mutations in GpIb␣ are unlikely to affect VWF self-association rates, the data suggest that the shear-driven binding of VWF to platelets is separable from protein self-association.
The precise conformation changes that promote VWF binding and proteolysis have not been determined. Choi et al 34 suggest that shear application between 2000 and 5000/s trigger protein conformation changes such that several amino acids in the D3 and C domains of VWF undergo shear-induced disulfide bond formation. Others also suggest that the native VWF-DЈD3 domain shields the VWF-A1 domain from binding platelet GpIb␣. 35 Finally, the proteolytic processing of VWF by ADAMTS13 under shear is enhanced by the binding of FVIII to the VWF-DЈD3 domain. 36 Thus, one possible model suggests that shear promotes the rearrangement of individual domains within the globular section of VWF, which contains both DЈD3 and A1. 21 This then enhances both Figure 5 . Platelet mechanotransduction by beads bearing immobilized VWF and anti-GpIb␣ mAb. A total of 10 7 platelets/mL were mixed with beads bearing either pVWF (A-B,D) or mAbs AP-1 against GpIb␣ (C,E) at various shear rates. Platelet:bead ratio was approximately 5:1. Anti-GpIb␣ blocking mAb AK2 was present in panel B, whereas there were no blocking reagents in panels A and C. Samples withdrawn at indicated times were incubated with CD31 PerCP-eFluor 710 and annexin-PE for 5 minutes and analyzed using flow cytometry. Cytometry forward versus side scatter was used to gate either singlet beads (Ai,Bi,Ci) or singlet platelets (Aii,Bii,Cii). (D-E) Distribution of active platelets that were either free (Aii,Bii,Cii top right quadrant) or bound (Ai,Bi,Ci top right quadrant) to beads was quantified. Percentage is based on total number of platelets in the sheared mixture read in cytometer. Beads without platelets appear in bottom left quadrant of Ai, Bi, Ci. *Platelet activation is higher at 3 minutes compared with 0 minutes at these shear rates (P Ͻ .05).
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VWF self-association on platelets is a shear stress-dependent process
In addition to conformation changes in solution, studies that apply shear to VWF and then analyze protein size using light scattering show that VWF subjected to shear more than 2300/s undergoes aggregation or self-association. 13 Although it has been suggested that VWF self-association may occur in the absence of shear, 37 these authors present data from enzyme-linked immunosorbent assay studies where VWF is immobilized on plastic plates. Such immobilization itself may alter the native conformation of the protein and promote self-association. In our system, which contains platelets, however, it is fluid shear stress that drives the accumulation of more than one VWF molecule on a single platelet GpIb␣ receptor. This is particularly evident in studies where variation in media viscosity using dextran enhances the extent of selfassociation ( Figure 4) . In studies performed with PRP also, ⌬A1-488 binding to platelets was only observed in the presence of shear ( Figure 3B ).
The mechanism of VWF self-association is not fully established. Savage et al 12 demonstrated that, although platelets alone fail to bind surfaces coated with immobilized ⌬A1-VWF, the adhesion of these cells to this substrate is enhanced if either VWF or ⌬A3-VWF (VWF lacking the A3 domain) is present in solution. Thus, self-association does not involve the homotypic binding of VWF-A1 or -A3 domains. Ulricht et al 37 suggest that multiple domain interactions probably contribute to VWF self-association. These authors demonstrate that proteolytically generated VWF fragments SpII (amino acids 1366-2050) and SpIII (amino acids 1-1365) in biotinylated forms are able to bind both immobilized SpII and SpIII in enzyme-linked immunosorbent assay. Finally, using a viscometer to apply shear and using MALDI-TOF/TOF for analysis, it has been shown that free thiols on the VWF surface may form new disulfide bonds on shear application. 34 These Cys residues, which are susceptible to thiol-disulfide exchange, are located in the C-domains and also the D3 domain of plasma VWF. Overall, although there is partial information on the mechanism of VWF self-association, further development of ⌬A1-488 and analogs of this reagent may reveal more precisely the molecular basis of this phenomenon. Such studies may reveal the extent to which VWF self-association in solution under shear precedes the accumulation of the molecular complex on platelet GpIb␣. Alternatively, it can allow us to determine whether VWF recruited on GpIb␣ has an altered conformation that is more prone to self-association compared with the native protein.
VWF self-association contributes to shear-induced platelet activation
The overall size of GpIb␣ may be a key feature controlling its ability to transmit mechanical outside-in signals. Electron microscopy observations of GpIb␣ suggest that the globular head section of this glycoprotein resembles a small sphere of radius 4.5 nm and that this domain is attached to cells via a slender stalk of length 35 nm. 38 Our microscopy images reveal that self-associated VWF bound to GpIb␣ resembles a clump, with only a few of the platelet GpIb␣ receptors being occupied by the aggregated protein ( Figure  3B ). Here, self-associated VWF effectively increases the "apparent" size of the GpIb␣ globular head section.
Based on our earlier work, 29 we estimate the magnitude of force applied on platelet GpIb␣ under the experimental conditions described in this manuscript (Table 1 ). According to this theory, at a shear stress of 100 dyne/cm 2 (shear rate of 10 000/s, 1 cp media viscosity), the maximum force applied on native GpIb␣ on platelets is small at approximately 0.1 pN. Attachment of a single VWF (radius ϳ 100 nm) to this receptor at the same shear stress increases the magnitude of applied shear force to 8 pN. Assuming that the self-associated VWF is 200 nm in size, we estimate that GpIb␣ bound to the self-associated protein complex experiences a peak force of 23 pN. A similar magnitude of force is applied when polystyrene beads with immobilized VWF or anti-GpIb␣ mAb are shear mixed with platelets at a low shear stress of 2 dyne/cm 2 . Attachment of GpIb␣ receptors located on adjacent platelets to a single VWF complex at 100 dyne/cm 2 can increase the magnitude of applied force to approximately 490 pN. Although some of these force estimates are large compared with the measured VWF-GpIb␣ bond rupture force 39 (11.4 pN) , it is necessary to note that these are peak instantaneous forces and they may be distributed over multiple GpIb␣ receptors on cells. Compared with these forces that are applied to platelets in suspension, forces in the order of 15 to 100 pN are applied to platelet-substrate bonds as these cells translocate on immobilized VWF at a shear rate of 2000/s. 40 Overall, VWF self-association on platelets in solution can enhance the magnitude of the applied shear force on GpIb␣ by increasing the apparent/effective radius of gyration at the receptor's globular head section. Under this condition, the mechanical force applied on platelet GpIb␣ in solution can rival that of platelets translocating on a substrate with immobilized VWF. Finally, the study also demonstrates the utility of antibody-coated beads to study receptormediated mechanotransduction.
Application of mechanical signals via GpIb␣ can trigger cell signaling events that lead to platelet activation and subsequent aggregation. In this regard, cell activation involves intracellular *The force applied between two spheres with radius a1 and a2 separated by a distance d was calculated. 29 Applied shear stress is 100 dyne/cm 2 (ie, shear rate ϭ 10 000/s and medium viscosity ϭ 1 cp) in all cases except for the case of platelet-bead interactions where shear stress was 2 dyne/cm 2 . Platelets are modeled as sphere with radius a1 ϭ 1.5 m. a2 and d are varied according to measured molecular dimensions of GpIb␣, VWF, platelets, and hypothetical size of self-associated VWF.
†In all cases, it is assumed that VWF or protein complex is bound to a single GpIb␣ receptor.
3996 DAYANANDA et al BLOOD, 11 NOVEMBER 2010 ⅐ VOLUME 116, NUMBER 19 personal use only.
For at STATE UNIV OF N Y AT BUFFAL on December 4, 2011. bloodjournal.hematologylibrary.org From calcium elevation and a complex interaction of numerous molecular pathways including, but not limited to, the phosphoinositide-3-kinase-Akt, Src/phospholipase C, immunoreceptor tyrosine-based activation motif, adhesion and degranulation promoting adapter protein, mitogen-activated protein kinase, thromboxane A 2 , and adenosine diphosphate driven pathways. 41 Together, these pathways contribute to the expression of phosphatidylserine on the outer leaflets of activated platelets and changes in the ligandbinding epitope of platelet receptor GpIIb-IIIa. Platelet receptors GpIb␣ and GpIIb-IIIa together mediate stable platelet aggregation under shear. 13, 42 In addition to these processes, it is suggested that shear-induced platelet-VWF interactions trigger GpIb␣ ectodomain shedding, and this may also contribute to regulating the kinetics of cell adhesion. 43 In conclusion, we demonstrate that VWF self-associates on platelet GpIb␣. Such self-association increases the multivalency of VWF, and this probably enhances the avidity of VWF-GpIb␣ interactions in the vasculature. High-binding avidities may be necessary for the sustained application of forces that contribute to SIPAct. In support of this, some clinical studies suggest that platelet activation under shear may contribute to the pathogenesis of acute myocardial infarction 44 and cerebral ischemia. 45 It is also suggested in an arterial stenosis model that SIPAct may act in synergy with vascular injury to regulate platelet aggregation in circulation. 46 Alternatively, enhanced VWF binding via selfassociation to single platelets or bridging between 2 platelets may enhance VWF A2-domain proteolysis by ADAMTS13. 8 In this regard, abnormal high shear stress in the vasculature, which is associated with aortic stenosis 47 and pulmonary arterial hypertension, 48 results in the loss of large VWF multimers. This can contribute to bleeding. Future studies in appropriate disease models will be necessary to delineate between the precise contributions of VWF self-association to platelet activation and its effect on protein multimer distribution.
